APA (7th ed.) Citation

Juratli, T., Jungk, C., & Miller, J. J. (2023). Journal of neuro oncology: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors. Journal of neuro-oncology, 162(3), . https://doi.org/10.1007/s11060-023-04317-3

Chicago Style (17th ed.) Citation

Juratli, Tareq, Christine Jungk, and Julie J. Miller. "Journal of Neuro Oncology: Diagnostic and Therapeutic Implications of IDH Mutations in Gliomas Following the 2021 World Health Organization Classification of CNS Tumors." Journal of Neuro-oncology 162, no. 3 (2023). https://doi.org/10.1007/s11060-023-04317-3.

MLA (9th ed.) Citation

Juratli, Tareq, et al. "Journal of Neuro Oncology: Diagnostic and Therapeutic Implications of IDH Mutations in Gliomas Following the 2021 World Health Organization Classification of CNS Tumors." Journal of Neuro-oncology, vol. 162, no. 3, 2023, https://doi.org/10.1007/s11060-023-04317-3.